The synergistic anticancer effects of ReoT3D, CPT-11, and BBI608 on murine colorectal cancer cells.

Abouzar Babaei Hoorieh Soleimanjahi Masoud Soleimani Ehsan Arefian

Published in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2020)

The present study highlights that combination of ReoT3D, CPT-11, and BBI560 showed synergistic anticancer activity against CT26 cell line. This modality might be considered as a new approach against colorectal cancer (CRC) in the in vivo and clinical trial investigations.

Keyphrases

clinical trial
cancer therapy
computed tomography
open label
image quality
phase ii
double blind
dual energy
phase iii